More than 20% of all patients treated with the implant had essentially no symptoms of depression after two years, researchers ...

The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under physician oversight.

Researchers from Hiroshima University in Japan and collaborating institutions have found that adults with asthma who ...

About 20% of U.S. adults experience major depression in their lifetime. For most people, symptoms improve within a few ...

Findings reveal that vagus nerve stimulation leads to lasting benefits in treatment-resistant depression, improving function ...

The FDA approved a prescription at-home brain neuromodulation therapy as an adjunctive depression treatment for adults, maker ...

Researchers compared a traditional Chinese medicine, Yueju Pill, with a standard antidepressant and found both reduced ...

Johnson & Johnson today announced a new analysis of Phase 3 data which found CAPLYTA® (lumateperone), in combination with an antidepressant, showed significantly greater remission rates in adults with ...

A review of recent studies suggests exercise may treat depression as effectively as therapy or antidepressants, offering an ...

In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved ...

At Stanford, a treatment that aims magnetic pulses at the brain is showing results for people with treatment-resistant ...

Adding a daily fish oil supplement to psychotherapy showed no significant benefit over placebo for kids and teens with moderate-to-severe major depressive disorder (MDD), a randomized trial showed.